The National Organization for Rare Disorders (NORD)


Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,150 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,150 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 

News Briefs

Researchers Identify Progeria Gene

A study that may have broad implications for better understanding the aging process has resulted in the identification of the gene responsible for Hutchinson-Gilford progeria syndrome, the most dramatic form of premature aging. The study will be released online next week (April 21, 2003) in the journal, Nature.

"The implications of our work may extend far beyond progeria-to each and every human being," said Francis S. Collins, MD, PhD, director of the National Human Genome Research Institute (NHGRI) and leader of the research team.

Children born with progeria appear to have an aging rate that is five to 10 times what is normal, according to another of the researchers, W. Ted Brown, MD, PhD, co-author of the study and a leading clinical expert on progeria. They usually appear normal at birth, but within a year their growth rate slows and their appearance begins to change. Typically, they become bald with aged-looking skin. They often suffer from symptoms, such as cardiovascular disease, typically seen in elderly people. There are currently no diagnostic tests or treatments for the progressive disorder, which is believed to affect one in eight million newborns worldwide.

The researchers determined that the most common cause of progeria is a single-letter "misspelling" in a gene on chromosome 1 that codes for lamin A, a protein that is a key component of the membrane surrounding the cell's nucleus. In every instance in the study, the parents were found to be normal, indicating that the misspelling was a new, or "de novo", mutation in the child.

The research team included members from the National Human Genome Research Institute, the Progeria Research Foundation, the New York State Institute for Basic Research in Developmental Disabilities in Staten Island, NY, the University of Michigan in Ann Arbor and Brown University in Providence, RI. For additional information, go to the Progeria Research Foundation's Web site (www.progeriaresearch.org).

Enter your name and e-mail address if you would like to receive "News Blasts" from NORD






ABOUT | CONTACT NORD

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

Previous News Briefs

ICORD 2008

FDA and European Union Adopt Shared Form

NORD Representatives Address Congress

CETT Increases Access to Genetic Tests

NORD Honors Innovators at 2007 Tribute Banquet

FDA Approves First Product for PNH

NORD Staff and Rare-Disease Researchers Describe Their Work for Wife of President of Germany

A Common Lesson of Rare Diseases

NORD Issues RFPs

Deadline Announced for Grant Applications

Conference in Korea Focuses on Rare Diseases

FDA Approves Revlimid For Multiple Myeloma

Penn Researchers Pinpoint Cause of FOP

FDA Approves HDE for Rare Disorder of Placenta

CFC Genes Identified With Help of Patient Organization

Saving Andy Martin’s Cells

Haffner Honored by Royal College of Physicians

NORD President Honored For Health Advocacy

NIH Opens New Clinical Research Hospital

Gulf War ALS Study Results Reported

Researchers Identify Progeria Gene

Dystonia Patients Gain Access to "Brain Pacemaker"

Scientists Block CJD-Like Illness in Mice

Genetic Signature Linked to Severe Lupus Symptoms

Genes Linked to Methylmalonic Aciduria Identified

French Researchers Claim a Cure for Severe Sickle Cell

NF1 Research: When a Good Gene Goes Bad

Thalidomide Shows Promise

For Smallpox: Vaccine Production on Target

NORD Member Organization Update August 2002

FDA Approves New "Orphan Drug"

Supreme Court Narrows Disability Law

Dramatic Results Reported in Stiff Person Syndrome Study

Gulf War Vets Have Higher Rate of ALS

Diseases of Bioterrorism

Stay connected!

If you liked these News Briefs, you’ll love our free e-mail News Blasts. You’ll receive breaking news affecting the rare-disease community directly in your inbox if you enter your e-mail address in the box at the top of this page.

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. NORD MARKETPLACE .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2006 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Friday, March 21, 2008